Therefore, we sequenced the SC4MOL gene that was predicted to encode this enzyme. Two variations from the published sequence were identified; 519T>A and 731A>G encoding H173Q and Y244C, respectively, in the sterol C4 methyl oxidase-like protein (Fig 3a) , herein referred to as sterol methyl oxidase (SMO). The 519T>A mutation was carried by the patient's father, and the 731A>G was carried by the mother. Both amino acids occur within highly conserved metal-binding domains in SMO (Fig 3b) . In addition, H173Q alters a predicted active site of the second iron-binding motif of the enzyme.
Plasma methylsterol levels were also elevated in the patient's parents (Fig 2c) . This suggests a subclinical effect for heterozygotes, in keeping with that seen in carriers of a DHCR14B/LBR mutation who have altered nuclear morphology in granulocytes (PelgerHuët anomaly) 3 . DHCR14B/LBR encodes C14-sterol reductase, immediately upstream of SMO, which also functions as a nuclear lamin B receptor 4 . Tight regulation of these two enzymes in the pathway underscores extra-sterol functions of 4, 4'-dimethylsterols.
The two most abundant dimethylsterols; 4, 4'-dimethyl-5 -cholesta-8,24-dien-3 -ol (testis-meiosis activating sterol (MAS)), and 4, 4'-dimethyl-5 -cholesta-8, 14, 24-trien-3 -ol (follicular fluid -MAS), substrates for SMO and C14-sterol reductase respectively, are members of the MAS family and are found in high concentration in testis and ovary.
The underlying mechanism of their extra-sterol function remains unknown. However since 4, 4'-dimethylsterols are either direct substrates or products of C14 sterol reductase, they could function as signaling sterols for nuclear lamin B receptor. The nuclear lamin B receptor is important for nuclear membrane breakdown during meiosis of germinal cells 5, 6 and formation of the mature granulocyte nucleus 7 . Granulocyte/neutrophil-rich pathology is characteristic of psoriasis and psoriatic arthritis 8, 9 . Thus the mild elevation of 4, 4'-dimethylsterols seen in the patient's father could be relevant to his history of mild inflammatory joint disease and a paternal family history of early onset inflammatory joint disease ( Supplementary Fig 1 online) .
Skin cell hyperproliferation causes flaking skin, characteristic of psoriasis. All known genetic disorders that cause increased levels of MASs, including defects in DHCR14/LBR, NSDHL and EBP (Fig 2b) 1,10,11 , present with ichythyosiform/psoriasiform dermatitis in humans and mice. However, none of the defects adjacent or distal to MAS demethylation complex, including CYP51, SC5D, or DHCR7, manifest skin lesions [12] [13] [14] . Previous studies of germinal cells have demonstrated meiosis-activating function of MAS 15, 16 , but the effect of MAS on cell cycle regulation and mitosis is unknown.
Therefore, we examined cell proliferation in patient skin fibroblasts (Fig 4a-c) . The rate of cell division was found to be higher in patient fibroblast than control cells cultured in cholesterol-depleted medium, a condition under which de novo cholesterol biosynthesis is stimulated (Fig 4a) . The S-G2-M to G0-G1 ratio in patient skin fibroblasts was >3-fold higher than control cells (Fig 4b) . This ratio peaked after 2-3 days growth in the cholesterol-depleted medium, and corresponded with peaks of cellular methylsterols and total protein (Supplementary Table 1 online) .
Growth of patient cells in cholesterol-depleted suggest association between MAS and cell division. To further examine this possibility, transformed human lymphoblasts were cultured in the presence of a SMO inhibitor, 3-amino-1,2,4-triazole (ATZ). Under these conditions, the cells accumulated a profile of methylsterols similar to that of the patient's lymphocytes grown without ATZ (data not shown). Parallel to this, the S-G2-M/G0-G1 ratio increased 3-fold in treated lymphoblasts, while neither simvastatin or fluconazole (an inhibitor of lanosterol 14 demethylase (CYP51)) had a significant effect on cell cycle progression (Fig 4c) . These data indicate alterations in SMO that in turn affects cell cycle activation.
Patients with genetic defects in NSDHL, which encodes the enzyme immediately downstream of SMO, occasionally present with symptoms nearly identical to those with defects in EBP 1,10,11 and vice versa; but they always differ in skin histopathology. Out of newborn period, NSDHL-deficient patients have psoriasiform dermatitis whereas EBPdeficient patients have ichthyosis, a condition associated with minor skin inflammation. Our patient, and NSDHL-deficient patients accumulate 4, 4'-dimethylsterols in their skin, but EBP-deficient patients do not. This suggests that dimethylsterols differ from other MAS in contributing to the perturbation of immune function. SC4MOL is located on 4q32-34, the known psoriasis susceptibility locus PSORS9 (4q31-34). Histologically, our patient's dermatitis is identical with that seen in classical psoriasis.
Since both the patient and her father had a significant elevation of dimethylsterols, we examined a comprehensive panel of immunologic parameters as described in the methods and Supplementary Table 2 -granulocytes in the patient and father, respectively, compared with healthy controls (Fig 4d) . Up-regulation of TLR-2, but not TLR-4, is considered typical for patients with psoriasis 17 or psoriatic arthritis 18 . Over-expression of TLR-2 and downregulation of TLR-4 on granulocytes suggest perturbation of innate immune responses to bacterial infection. Consistent with this observation, expression of granulocyte-specific, CD16b isoform was also markedly down-regulated in both patient and father (Fig 4e) , suggesting a defect in phagocytic function.
In the lymphocyte compartment, both patient and father had significantly higher proportions of CD8 dim T cells that were also CD28 null CD56 + (Fig 4d, Supplementary  Table 3 ). Down-regulation of CD8 and CD28, and accumulations of CD28 null CD56
+ T cells are indicative of pervasive immune activation in the setting of chronic inflammatory disease 19 .
We then examined whether inhibiting SMO by ATZ affected normal leukocytes. Results showed over 6-fold increase in TLR-2 + TLR-4 -granulocyte population (Fig 4f) , and 2-fold decrease in CD8 expression in normal lymphocytes (Supplementary Table 4 online). These results recapitulated the in vivo granulocyte and T cell phenotypes of the patient and father (Fig 4d) . All these data indicate a link between cholesterol homeostasis and immunity.
Because psoriasis and psoriatic arthritis are known to be driven by the production of certain cytokines, including tumor necrosis factor (TNF)-and interleukin (IL)-6, the serum cytokine profiles of the patient and father were investigated by multiplex assay (Supplementary Table 5 online). Consistent with the flow cytometry data, a number of cytokines and chemokines associated with granulocyte and monocyte activation were elevated in the patient, and to a lesser extent in her father. This included granulocyte and monocyte colony stimulation factor, which is known to trigger psoriasiform eruption in humans 20 . The patient also had elevated IL-6 and IL-8 (Supplementary Table 5 online), cytokines that amplify skin inflammation as has been demonstrated in psoriatic skin and fibroblasts 21 .
The classical pro-inflammatory cytokine TNF-was normal in the patient, consistent with the fact that her dermatitis did not respond to treatment with etanercept. Cultures of patient skin fibroblasts showed constitutive production of IL-6 compared to control fibroblasts regardless of passage number (Fig 4g) , and were further increased with the addition of recombinant TNF-a known inducer of IL-6. To investigate a possible association of the defect in cholesterologenesis and cytokine production, we treated control and patient fibroblasts with simvastatin, which blocks cholesterol biosynthesis upstream of SMO. After 24 hours, IL-6 production by patient fibroblasts was significantly decreased even in the presence of exogenous TNF- (Fig 4g) , suggesting that the accumulated sterol intermediates in our patient were stimulating IL-6 production.
In summary, we have identified the first patient deficient in SMO, a novel enzyme in the C4 methylsterol demethylation complex that is encoded by SC4MOL. Our data suggest a role for SMO in regulating granulocyte activation, CD8 expression on T cells, cytokine production, and cell proliferation, factors that are critical in the pathogenesis of common psoriasis. We have previously reported elevated methylsterols in skin flakes from patients with common psoriasis 22 . Thus variation in expression or function of SMO may be an important modifying factor in the development of common psoriasis.
Methods
This study was conducted pursuant to an IRB protocols approved by the University of Pittstburgh.
Genomic DNA and cDNA amplification and sequencing. Total RNA and gDNA was extracted from patient fibroblasts for reverse transcription, PCR amplification, and sequencing as described 23 . Six exons of SC4MOL were amplified using intronic primers (all primer sequences available upon request).
Sterol analyses. Sterol distribution was measured in cultured skin fibroblasts, transformed lymphocytes, serum, or skin flakes obtained from patients and controls by GC and selected-ion MS as described 11, 24 .
Flow cytometry on peripheral blood cells
Flow cytometry on cells from patient and controls were carried out and analyzed as described previously 19, 21 . In the sterol oxidase inhibition studies, 10 ml of erythrocytedepleted blood from a healthy 16-year old girl was incubated with 5mM ATZ for 60 hours at 37 degree with 5% C0 2 , both ATZ treated and untreated total leukocytes were then isolated and stained as described in Supplementary Table 2 online.
Serum cytokine quantification. Cytokine levels were determined by multiplex assay using the Luminex system (Luminex Corporation) as described previously 25, 26 .
Cell culture, proliferation and ELISA. Primary dermal fibroblasts were cultured in DMEM supplemented with 10% FBS, 100 U/ml penicillin, 100 mg/ml streptomycin and GlutaMAX (Invitrogen), TNF-(10ng/ml) and simvstastin (5 M) were added to fibroblasts at 80% confluency, and culture media were collected after 24 hours for measurement of IL-6 using an ELISA kit (BD Bioscience). For cell proliferation assays, primary fibroblasts or EBV-transformed human lymphoblasts were cultured with cholesterol-depleted medium as described 24 ; and ATZ (2mM), simvstastin (5 M) or fluconazole (12.5 M) were added to the medium before the cells were subjected to the proliferation assay.
Cell proliferation and cell cycle stage analysis
Skin fibroblasts, or EBV-transformed lymphoblast (2 x 10 7 cells/ml) were labeled with 0.25 M of 5-(and 6-) carboxyfluorescein diacetate succinimidyl ester (CFSE; Molecular Probes) using established procedures 20 . At different days of culture, cells were harvested and stained with 4',6'-diamidino-2-phenylindole (DAPI), and analyzed by multicolor flow cytometry. The number of cell divisions was determined by the number of CFSE fluorescence peaks. The number of cells in G0-G1 and in the S-G2-M phases of the cell cycle was proportional to the amount of linear DAPI fluorescence, G0-G1 cells having half the amount of DAPI staining as the S-G2-M cells. 27 . c. Plasma sterol analysis and plasma total cholesterol levels from controls, the patient before cholesterol supplementation and after 3 months of cholesterol supplementation, and the patient's mother and father. Methylsterols levels are the sum of both dimethylsterols and monomethylsterols. After 3 month of cholesterol supplementation, a 19% reduction in the patient's plasma methylsterol level was seen, together with an increase of her total cholesterol level. After 6 month of cholesterol supplementation, the patient's total cholesterol normalized, however no further reduction of methylsterols was seen (data not shown). a. Two mutations were identified in SC4MOL from both gDNA and cDNA extracted from peripheral blood leukocytes, T519>A and A731>G. T519>A was also identified in gDNA from patient's father, and A731>G was identified in her mother. b. Alignment of SMO protein sequences across evolution. From yeast to human, SC4MOL is highly conserved. Four conserved metal-binding domains were identified and are highlighted with black squares. The conserved metal binding motifs HXXXH/D and HXXHH are marked under the alignment. T519>A changes amino acid H173 to Q, which replaces the histidine at an active site of the second metal binding domain with glutamine; A731>G changes amino acid Y244 to C; Y244 is in the fourth metal binding domain and also is conserved across evolution. . No significant differences were observed in the monocyte population (data not shown). f. Cytometric profiles for TLR-2 and TLR-4 on granulocytes of healthy control with (blue) or without (red) ATZ treatment. Overlay of cytograms show ATZ-induced phenotypic shift towards increased TLR-2 expression. g; IL-6 production by dermal fibroblasts from healthy control and patient upon treatment of TNF-, and TNF-plus simvastatin, or in media alone.
